Circulation , 133 (4), e38e360
Insurance companies typically do not cover Wegovy or Ozempic for obesity, as weight management is not considered a medical necessity
Your healthcare provider will handle that on your behalf
While both medications showed a significant weight loss benefit, after 72 weeks on treatment, people treated with Zepbound lost 20% of their body weight, compared to people on Wegovy who lost just under 14%
According to the SmPC, the following frequencies have been observed: Nausea (very common: may affect more than 1 in 10 people) Diarrhoea (very common: may affect more than 1 in 10 people) Vomiting (very common: may affect more than 1 in 10 people) Constipation (common: may affect up to 1 in 10 people) Abdominal pain and discomfort (common: may affect up to 1 in 10 people) Decreased appetite (very common: may affect more than 1 in 10 people) These effects typically diminish over time as the body adjusts to the medication, and gradual dose escalation helps minimise their severity
These fine needles minimize discomfort and tissue trauma while allowing accurate measurement of small volumes
